@article{52bb17dc1869468594ea056a082b7ef8,
title = "More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study",
keywords = "DAA, HCV, PWID, adherence, drug use",
author = "Moonseong Heo and Irene Pericot-Valverde and Jiajing Niu and Norton, {Brianna L.} and Akiyama, {Matthew J.} and Shadi Nahvi and Arnsten, {Julia H.} and Litwin, {Alain H.}",
note = "Funding Information: The parent PREVAIL trial is registered in ClinicalTrial.gov (NCT01857245). We are grateful for the collaborative support from the Addiction Medicine Center at the Prisma Health in Greenville, South Carolina. The contents of the work are solely the responsibility of the authors and do not necessarily represent the views of the funding agencies or the U.S. government. Funding Information: The work was supported in part by grants from the National Institutes of Health (R01DA034086 and K99/R00DA043011) and from Gilead Sciences (IN‐337‐1779). ",
year = "2023",
month = feb,
doi = "10.1111/jvh.13756",
language = "English (US)",
volume = "30",
pages = "172--175",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",
number = "2",
}
